Massachusetts Vol.27 (corporations: ImmunoGen)

World Vol.54 (Eastern Europe, U.S.)

Ohio Vol.7 (corporations: Cardinal Health)

New York Vol.38 (corporations: Henry Schein)

Georgia Vol.7 (Atlanta Journal-Constitution, Gwinnett Daily Post, Savannah Morning News, Augusta Chronicle)

UK Vol.173 (pharmaceutical corporations: Seqirus) / Australia Vol.30

cf. Pennsylvania Vol.11 (corporations: CSL Behring) / Australia Vol.29

Our Story | CSL

Fluad In-Season | Seqirus US
Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market (07/30/2020) |
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. | @nlm_news
Seqirus Announces U.S. FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine (02/03/2020) | @YahooFinance
First Adjuvanted Quadrivalent Influenza Vaccine by Seqirus Receives EU Approval (08/06/2020) | CISION
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine (12/11/2019) | CISION
Seqirus Ships Northern Hemisphere Flu Vaccines (07/15/2019) | precision vaccinations
Human Vaccines Project and Seqirus partner to advance universal flu vaccine research (28/06/2018) | @EurekAlert
Joint media release from Invest Liverpool, the Mayor of Liverpool and Seqirus (25/02/2017) | Seqirus
CSL completes purchase of Novartis’ flu vaccine business (08/03/2015) | @FiercePharma

Denmark Vol.3 (pharmaceutical corporations: Genmab)

Belgium Vol.4 (pharmaceutical corporations: Janssen Pharmaceutica)

cf. New Jersey Vol.9 (corporations: Johnson & Johnson)

Pennsylvania Vol.13 (corporations: Inovio Pharmaceuticals)

Maryland Vol.9 (corporations: Novavax)

World Vol.51 (mainly on U.S.)

Michigan Vol.11 (corporations: Stryker)

Pennsylvania Vol.12 (corporations: Mylan)

New Jersey Vol.12 (corporations: Amicus Therapeutics)

California Vol.28 (corporations: Halozyme Therapeutics)

Halozyme Therapeutics Enters Lucrative Agreement With Pfizer | Drug Development & Delivery
Halozyme Therapeutics Inc (HALO) Q2 2020 Earnings Call Transcript (08/11/2020) | The Motley Fool
Halozyme Therapeutics Inc. | MarketWatch
Halozyme Therapeutics Inc (HALO:NASDAQ) | CNBC
Halozyme Therapeutics Inc. | WSJ Markets
Halozyme Therapeutics Inc. (HALO) | yahoo! finance
Halozyme Therapeutics Inc | Bloomberg
HALO | finviz

Massachusetts Vol.25 (corporations: Sarepta Therapeutics)

World Vol.50 (U.S., New Zealand, U.K., Australia, etc.)

New Jersey Vol.11 (corporations: PTC Therapeutics)

Massachusetts Vol.24 (corporations: Alexion Pharmaceuticals)